Latest Market News

Nyrada Inc has responded to ASX inquiries confirming the timely and compliant disclosure of positive safety data from its Phase I clinical trial of Xolatryp. The company detailed the timeline of its awareness and release of information, affirming adherence to continuous disclosure rules.

Red Mountain Mining Ltd has announced a pro-rata non-renounceable entitlement issue of RMXO Options priced at $0.001 each, aiming to raise up to $193,499 to support its working capital needs. The offer, exercisable at $0.02 until May 2027, carries notable risks including dilution and going concern uncertainties.

Pro Medicus Limited reports a record-breaking year with $520 million in new contracts and a surge in cloud adoption, setting the stage for continued growth. The company also advances its AI and cardiology offerings, reinforcing its market position.

Carnegie Clean Energy launches a $3 million Share Purchase Plan to fuel commercialisation of its wave and MoorPower technologies, capitalising on growing global momentum in ocean energy.

Dundee Precious Metals Inc. shareholders have overwhelmingly approved a key resolution and a corporate name change, clearing a major hurdle in their recommended acquisition of Adriatic Metals Plc. This milestone sets the stage for the final court sanction and subsequent integration steps.

Pro Medicus Limited has announced a fully franked ordinary dividend of AUD 0.30 per share for the fiscal year ending June 30, 2025, signaling steady returns for shareholders.

MinRex Resources’ recent drilling at the Fraser Range Project in Western Australia reveals promising rare earth and titanium mineralisation, despite no copper-gold discoveries. The company now faces a pivotal decision on advancing its stake in the project.

MFF Capital Investments reported a robust $447 million net profit for FY25 alongside a 17 cents per share fully franked dividend, underscoring its disciplined long-term investment strategy and expanding internal capabilities.

Viva Leisure has reported a robust FY2025 with record membership and a 30% jump in revenue, driven by strategic acquisitions and a booming technology segment. The company’s multi-brand approach and expanding network position it strongly for future growth.

Pro Medicus Limited has delivered a record-breaking FY2025 with soaring profits and a wave of major US healthcare contracts, setting the stage for continued expansion.

Viva Leisure has reported its strongest financial year ever, with record revenue and membership growth driven by strategic acquisitions and technology expansion.

Pro Medicus Limited has reported a robust FY25 with revenue climbing nearly 32% and net profit up 39%, prompting a significant dividend increase.